GS protein mutations and the pathogenesis and function of pituitary tumors

Metabolism: Clinical and Experimental

Volumn 45, Issue SUPPL.1, 1996, Pages 120-122

  Harris, P E ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MEMBRANE RECEPTOR;

ARTICLE; CARCINOGENESIS; ENZYME ACTIVATION; GENE MUTATION; HORMONE SYNTHESIS; HUMAN; HYPOPHYSIS TUMOR; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECEPTOR BINDING; GENETICS; MUTATION; PATHOPHYSIOLOGY; REVIEW;

GTP-BINDING PROTEINS; HUMANS; MUTATION; PITUITARY NEOPLASMS;

EID: 0030209740     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90104-3     Document Type: Article

References (23)

1. Vallar L, Spada A, Giannattasio G: Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas. Nature 330:566-568, 1987
2. Landis AC, Masters SB, Spada A, et al: GTPase inhibiting mutations activate the α chain of Gs and stimulate adenylyl cyclase in human pituitary tumours. Nature 340:592-596, 1989
3. Spada A, Arosio M, Bochicchio D, et al: Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumours with or without constitutively active adenylyl cyclase. J Clin Endocrinol Metab 71:1421-1426, 1990
4. Adams EF, Lei T, Buchfelder M, et al: Biochemical characteristics of human pituitary somatotrophinomas with and without gsp mutations: In vitro cell culture studies. J Clin Endocrinol Metab 80:2077-2081, 1995
5. Bertherat J, Chanson P, Montminy M: The cyclic adenosine 3′,5′-monophosphate-responsive factor CREB is constitutively activated in human somatotroph adenomas. Mol Endocrinol 9:777-783, 1995
6. Alexander JM, Biller BM, Bikkal H, et al: Clinically nonfunctioning pituitary tumours are monoclonal in origin. J Clin Invest 86:336-340, 1990
7. Herman V, Fagin J, Gonsky R, et al: Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427-1433, 1990
8. Biller BM, Alexander JM, Zervas NT, et al: Clonal origins of adrenocorticotropin-secreting pituitary tissue in Cushing's disease. J Clin Endocrinol Metab 75:1303-1309, 1992
9. Landis CA, Harsh G, Lyons J, et al: Clinical characteristics of acromegalic patients whose pituitary tumors contain mutant Gs protein. J Clin Endocrinol Metab 71:1416-1420, 1990
10. Lyons J, Landis CA, Harsh G, et al: Two G protein oncogenes in human endocrine tumours. Science 249:655-659, 1990
11. Harris PE, Alexander JM, Bikkal HA, et al: Glycoprotein hormone á-subunit production in somatotroph adenomas with and without Gs mutations. J Clin Endocrinol Metab 75:918-923, 1992
12. Drews RT, Gravel RA, Collu R: Identification of G protein α-subunit mutations in human growth hormone (GH)- and GH/ prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis. Mol Cell Endocrinol 87:125-129, 1992
13. Yoshimoto K, Iwahana H, Fukuda A, et al: Rare mutations of the Gs alpha subunit gene in human endocrine tumors. Cancer 72:1386-1393, 1993
14. Hosoi E, Yokogoshi Y, Hosoi E, et al: Analysis of the Gs α gene in growth hormone-secreting pituitary adenomas by the polymerase chain reaction-direct sequencing method using paraffin-embedded tissues. Acta Endocrinol 129:301-306, 1993
15. Tordjman K, Stern N, Ouaknine G, et al: Activating mutations of the Gs α-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 77:765-769, 1993
16. Williamson EA, Daniels M, Foster S, et al: Gsα and Gi2α mutations in clinically non-functioning pituitary tumours. Clin Endocrinol 41:815-820, 1994
17. Gertz BJ, Contreras LN, McComb DJ, et al: Chronic administration of corticotropin-releasing hormone increases pituitary corticotroph number. Endocrinology 120:381-388, 1987
18. Williamson EA, Ince PG, Harrison D, et al: G-protein mutations in human pituitary adenocorticotrophic hormone-secreting adenomas. Eur J Clin Invest 25:128-131, 1995
19. Burton FH, Hasel KW, Bloom FE, Sutcliffe JG: Pituitary hyperplasia and giantism in mice caused by a cholera toxin transgene. Nature 350:74-77, 1991
20. Asa SL, Kovacs K, Stefaneanu L, et al: Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 131:2083-2089, 1992
21. Tian J, Chen J, Bancroft C: Expression of constitutively active Gs α-subunits in GH3 pituitary cells stimulates prolactin promoter activity. J Biol Chem 269:33-36, 1994
22. Gaiddon C, Boutillier A-L, Monnier D, et al: Genomic effects of the putative oncogene Gsa. J Biol Chem 269:22663-22671, 1994
23. Ma YH, Landis C, Tchao N, et al: Constitutively active stimulatory G protein αs in ß-cells of transgenic mice causes counterregulation of the increased adenosine 3′,5′-monophosphate and insulin secretion. Endocrinology 134:42-47, 1994